61382-Weerawarna, Pathum

Pathum Weerawarna, PhD

Assistant Research Professor of Medicine

L3 208
Indianapolis, IN
Pubmed Logo


Dr. Pathum Weerawarna is an experienced researcher in the medicinal chemistry field. He has conducted many successful early drug discovery research projects that involved target-based and phenotype-based drug-discovery approaches. These research projects focused on finding novel therapeutics and tackled essential questions related to infectious diseases and neurological disorders.

Dr. Weerwarna received a PhD in Chemistry (2016) from Wichita State University. His doctoral work mainly focused on the structure-guided design, synthesis, and evaluation of macrocyclic and dipeptidyl inhibitors of norovirus 3-chymotrypsin-like protease (3CLpro). He then completed a postdoctoral fellowship at Northwestern University, Department of Chemistry, under the mentorship of Prof. Richard B Silverman. As a postdoctoral fellow, Dr. Weerawarna conducted theoretical and mechanistic studies to understand the inactivation mechanism of GABA-AT by two of the leading mechanism-based inactivators (MBIs), CPP-115 and OV329, discovered by the Silverman group. These two drugs are currently under pre-clinical studies as potential therapeutics for treating epilepsy and addiction. He was also involved in a target deconvolution research project related to Amyotrophic Lateral Sclerosis (ALS), where he conducted photoaffinity labeling experiments to identify the biological targets of a lead neuroprotective compound.

Dr. Weerawarna joined the Indiana University School of Medicine in early 2022 as an Assitant Research Professor in the Division of Clinical Pharmacology. He is a member of the IUSM-Purdue TREAT-AD Center, where his research is mainly focused on conducting target-based drug discovery research to develop small molecule inhibitors of kinases as a potential treatment for Alzheimer's Disease.

Key Publications

Weerawarna, P. M.; Moschitto, M. J.; Silverman, R. B. Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115. ACS Chem. Biol. 2021,.

Juncosa, J. I.; Takaya, K.; Le, H. V.; Moschitto, M. J.; Weerawarna, P. M.; Mascarenhas, R.; Liu, D.; Dewey, S. L.; Silverman, R. B. Design and Mechanism of ( S )-3-Amino-4-(Difluoromethylenyl)Cyclopent-1-Ene-1-Carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction. J. Am. Chem. Soc. 2018, 140 (6), 2151–2164. https://doi.org/10.1021/jacs.7b10965.

Weerawarna, P. M.; Kim, Y.; Galasiti Kankanamalage, A. C.; Damalanka, V. C.; Lushington, G. H.; Alliston, K. R.; Mehzabeen, N.; Battaile, K. P.; Lovell, S.; Chang, K.-O.; Groutas, W. C. Structure-Based Design and Synthesis of Triazole-Based Macrocyclic Inhibitors of Norovirus Protease: Structural, Biochemical, Spectroscopic, and Antiviral Studies. Eur. J. Med. Chem. 2016, 119, 300–318. https://doi.org/10.1016/j.ejmech.2016.04.013.

Mandadapu, S. R.; Weerawarna, P. M.; Prior, A. M.; Uy, R. A. Z.; Aravapalli, S.; Alliston, K. R.; Lushington, G. H.; Kim, Y.; Hua, D. H.; Chang, K.-O.; Groutas, W. C. Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus. Bioorg. Med. Chem. Lett. 2013, 23 (13), 3709–3712. https://doi.org/10.1016/j.bmcl.2013.05.021.

Full List of Publications

Link:  https://scholar.google.com/citations?user=cnxlU1IAAAAJ&hl=en

Titles & Appointments

  • Assistant Research Professor of Medicine

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor